Investigation of the Correlation Between the Polymorphism/Expression Level of RANTES and Its Receptor CCR5 Gene Promoter and Type 2 Diabetes Mellitus

被引:4
|
作者
Chen, Jie [1 ]
Guo, Weichang [2 ]
Yin, Hejia [1 ]
Ma, Liju [3 ]
Li, Shaoyou [4 ]
Li, Huifang [1 ,5 ]
机构
[1] Kunming Med Univ, Dept Diabet, Affiliated Hosp 1, Kunming 650032, Peoples R China
[2] Kunming Med Univ, Dept Phys Educ, Kunming 650032, Peoples R China
[3] Kunming Med Univ, Dept Clin Lab, Affiliated Hosp 1, Kunming 650032, Peoples R China
[4] Kunming Med Univ, Dept Sci Res Lab Ctr, Affiliated Hosp 1, Kunming 650032, Peoples R China
[5] Kunming Med Univ, Dept Diabet, Affiliated Hosp 1, 295 Xichang Rd, Kunming 650032, Peoples R China
关键词
type; 2; diabetes; inflammation; cytokines; gene polymorphism; RANTES; CCR5; MICROVASCULAR COMPLICATIONS; CHEMOKINE; EXPRESSION; INFLAMMATION; ASSOCIATION; DISEASE; RISK; PROGRESSION; CCL5;
D O I
10.2147/DMSO.S398264
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to explore relationship among RANTES -28 (rs2280788) C/G polymorphism or CCR5 59029 (rs1799987) A/G polymorphism, level of self-expression, and type 2 diabetes mellitus (T2DM).Materials and Methods: Clinical data were collected from 92 subjects with normal blood glucose (NC) and 97 patients with T2DM (DM). CCR5 levels on the surface of monocyte/lymphocyte and plasma RANTES levels were detected by flow cytometry. TaqMan real-time fluorescent quantitative PCR was used to detect genetic polymorphisms of RANTES rs2280788 and CCR5 rs1799987.Results: There were no significant differences in frequencies of CCR5 rs1799987 genotype and A/G allele and frequencies of RANTES rs2280788 genotype and C/G allele, between subjects in NC and DM group (P > 0.05). Plasma RANTES level in DM group was significantly lower than NC group (P < 0.05), and difference came from patients with T2DM using insulin and subjects with normal blood glucose. CCR5 levels on the surface of monocytes and lymphocytes of patients in DM group were higher than NC group (P < 0.05). There was no significant difference in CCR5 level on the surface of monocytes and lymphocytes (or plasma RANTES level) among different genotypes of CCR5 rs1799987 (or RANTES rs2280788) (P > 0.05). RANTES level was positively correlated with age and TC and negatively correlated with diabetes course and HbA1c. CCR5 level on the surface of monocytes was positively correlated with drinking years, HbA1c, course of diabetes, and negatively correlated with TC. CCR5 on lymphocyte surface was positively correlated with diabetes course, smoking years, HbA1c, and negatively correlated with LDL, TC, HDL (P < 0.05).Conclusion: RANTES-28 (rs2280788) C/G polymorphism or CCR5 59029 (rs1799987) A/G polymorphism may not be associated with T2DM of Han nationality in Kunming and cannot affect RANTES and CCR5 expression. RANTES and CCR5 levels may be related to T2DM but may also be affected by age, blood lipids, HbA1c, diabetes course, drugs, and other factors.
引用
收藏
页码:213 / 223
页数:11
相关论文
共 50 条
  • [1] Expression of chemokine receptor CCR5 and CCR3 in Type 1 diabetes mellitus
    Liu, Y
    Chen, J
    Liu, C
    DIABETOLOGIA, 2002, 45 : A119 - A119
  • [2] Evaluation of the expression of chemokine receptor CCR5 in obese patients with diabetes mellitus type 2
    Bogdanski, P
    Pupek-Musialik, D
    Jagodzinski, P
    Kujawa, A
    Miczke, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 85 - 85
  • [3] Chemotactic Cytokine Receptor 5 (CCR5) Gene Promoter Polymorphism (rs1799987) Is Associated with the Risk of Diabetic Kidney Disease in Polish Patients with Type 2 Diabetes
    Nabrdalik, Katarzyna
    Pokrzywnicka, Patrycja S.
    Kwiendacz, Hanna
    Adamczyk, Piotr
    Moczulski, Dariusz
    Moczulska, Hanna
    Drozdz, Karolina
    Grzeszczak, Wladyslaw
    Gumprecht, Janusz
    DIABETES, 2020, 69
  • [4] Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus
    Bogdanski, P.
    Pupek-Musialik, D.
    Dytfeld, J.
    Jagodzinski, P. P.
    Jablecka, A.
    Kujawa, A.
    Musialik, K.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007, 45 (10) : 563 - 567
  • [5] CCR5 gene promoter polymorphism (59029A/G) associated with nephropathy in type 2 diabetic patients
    Tanaka, Y
    Mokubo, A
    Nakajima, K
    Watada, H
    Hirose, T
    Kawamori, R
    DIABETES, 2005, 54 : A199 - A199
  • [6] CCR5Δ32 genotype is associated with outcome in type 2 diabetes mellitus
    Muntinghe, Friso L. H.
    Gross, Sascha
    Bakker, Stephan J. L.
    Landman, Gijs W. D.
    van der Harst, Pim
    Bilo, Henk J. G.
    Navis, Gerjan
    Zuurman, Mike W.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 86 (02) : 140 - 145
  • [7] Physical Exercise Reduces the Expression of RANTES and Its CCR5 Receptor in the Adipose Tissue of Obese Humans
    Baturcam, Engin
    Abubaker, Jehad
    Tiss, Ali
    Abu-Farha, Mohamed
    Khadir, Abdelkrim
    Al-Ghimlas, Fahad
    Al-Khairi, Irina
    Cherian, Preethi
    Elkum, Naser
    Hammad, Maha
    John, Jeena
    Kavalakatt, Sina
    Lehe, Cynthia
    Warsame, Samia
    Behbehani, Kazem
    Dermime, Said
    Dehbi, Mohammed
    MEDIATORS OF INFLAMMATION, 2014, 2014
  • [8] Influence of nucleotide polymorphisms in the CCR2 gene and the CCR5 promoter on the expression of cell surface CCR5 and CXCR4
    Shieh, B
    Liau, YE
    Hsieh, PS
    Yan, YP
    Wang, ST
    Li, C
    INTERNATIONAL IMMUNOLOGY, 2000, 12 (09) : 1311 - 1318
  • [9] Risk of nephropathy in type 1 diabetes (DN) is associated with polymorphisms in RANTES receptor gene (CCR5):: Gender-related effect
    Mlynarski, WM
    Wolkow, PP
    Bochenski, JP
    Placha, G
    Poznik, D
    Krolewski, AS
    DIABETES, 2004, 53 : A505 - A505
  • [10] Association of GCK Gene Promoter Polymorphism and their Role in its MRNA Expression among Type 2 Diabetes Mellitus Patients
    Fatima, Waseem
    Khan, Farah
    Ali, Ashraf
    Verma, Amit Kumar
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (10)